Publication
Exploring Therapeutic Advances: A Comprehensive Review of Intestinal Microbiota Modulators
| dc.contributor.author | Pires, Lara | |
| dc.contributor.author | González-Paramás, Ana María | |
| dc.contributor.author | Heleno, Sandrina A. | |
| dc.contributor.author | Calhelha, Ricardo C. | |
| dc.date.accessioned | 2024-10-16T08:29:02Z | |
| dc.date.available | 2024-10-16T08:29:02Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | The gut microbiota establishes a mutually beneficial relationship with the host starting from birth, impacting diverse metabolic and immunological processes. Dysbiosis, characterized by an imbalance of microorganisms, is linked to numerous medical conditions, including gastrointestinal disorders, cardiovascular diseases, and autoimmune disorders. This imbalance promotes the proliferation of toxin-producing bacteria, disrupts the host’s equilibrium, and initiates inflammation. Genetic factors, dietary choices, and drug use can modify the gut microbiota. However, there is optimism. Several therapeutic approaches, such as probiotics, prebiotics, synbiotics, postbiotics, microbe-derived products, and microbial substrates, aim to alter the microbiome. This review thoroughly explores the therapeutic potential of these microbiota modulators, analysing recent studies to evaluate their efficacy and limitations. It underscores the promise of microbiota-based therapies for treating dysbiosis-related conditions. This article aims to ensure practitioners feel well-informed and up to date on the most influential methods in this evolving field by providing a comprehensive review of current research. | pt_PT |
| dc.description.sponsorship | The authors are grateful to the Foundation for Science and Technology (FCT, Portugal) for financial support through national funds FCT/MCTES (PIDDAC) to CIMO; UIDB/00690/2020 (https://doi.org/10.54499/UIDB/00690/2020) and UIDP/00690/2020 (https://doi.org/10.54499 /UIDP/00690/2020) and SusTEC; LA/P/0007/2020 (https://doi.org/10.54499/LA/P/0007/2020); through the institutional scientific employment program-contract with Sandrina A. Heleno; and through the Mush4Chol project (https://doi.org/10.54499/2022.08844.PTDC). | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Pires, Lara; González-Paramás, Ana M.; Heleno, Sandrina A.; Calhelha, Ricardo C. (2024). Exploring Therapeutic Advances: A Comprehensive Review of Intestinal Microbiota Modulators. Antibiotics. ISSN 2079-6382. 13:8, p. 1-27 | pt_PT |
| dc.identifier.doi | 10.3390/antibiotics13080720 | pt_PT |
| dc.identifier.issn | 2079-6382 | |
| dc.identifier.uri | http://hdl.handle.net/10198/30420 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | MDPI | pt_PT |
| dc.relation | Mountain Research Center | |
| dc.relation | Mountain Research Center | |
| dc.relation | Associate Laboratory for Sustainability and Tecnology in Mountain Regions | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Dysbiosis | pt_PT |
| dc.subject | Therapeutic interventions | pt_PT |
| dc.subject | Probiotics and prebiotics | pt_PT |
| dc.subject | New microbiome-modifying | pt_PT |
| dc.subject | Gut modulation | pt_PT |
| dc.title | Exploring Therapeutic Advances: A Comprehensive Review of Intestinal Microbiota Modulators | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | Mountain Research Center | |
| oaire.awardTitle | Mountain Research Center | |
| oaire.awardTitle | Associate Laboratory for Sustainability and Tecnology in Mountain Regions | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00690%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F00690%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/LA%2FP%2F0007%2F2020/PT | |
| oaire.citation.endPage | 27 | pt_PT |
| oaire.citation.issue | 8 | pt_PT |
| oaire.citation.startPage | 1 | pt_PT |
| oaire.citation.title | Antibiotics | pt_PT |
| oaire.citation.volume | 13 | pt_PT |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| person.familyName | Heleno | |
| person.familyName | Calhelha | |
| person.givenName | Sandrina A. | |
| person.givenName | Ricardo C. | |
| person.identifier.ciencia-id | 8B18-3095-6FC9 | |
| person.identifier.ciencia-id | F313-E3CE-554E | |
| person.identifier.orcid | 0000-0001-7224-1098 | |
| person.identifier.orcid | 0000-0002-6801-4578 | |
| person.identifier.rid | L-5951-2014 | |
| person.identifier.rid | J-2172-2014 | |
| person.identifier.scopus-author-id | 30067731800 | |
| person.identifier.scopus-author-id | 6507978333 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | e89b5bf5-d315-49b6-871e-fa8eb6030676 | |
| relation.isAuthorOfPublication | 2d5d1a41-7561-4a01-871c-b4c97da35053 | |
| relation.isAuthorOfPublication.latestForDiscovery | e89b5bf5-d315-49b6-871e-fa8eb6030676 | |
| relation.isProjectOfPublication | 29718e93-4989-42bb-bcbc-4daff3870b25 | |
| relation.isProjectOfPublication | 0aac8939-28c2-46f4-ab6b-439dba7f9942 | |
| relation.isProjectOfPublication | 6255046e-bc79-4b82-8884-8b52074b4384 | |
| relation.isProjectOfPublication.latestForDiscovery | 29718e93-4989-42bb-bcbc-4daff3870b25 |
